All lobbying filings
Arnold & Porter Kaye Scholer LLP
Arnold & Porter Kaye Scholer LLP filed a Q2 report for Sumitomo Pharma America, Inc. on July 17, 2026, reporting $60,000 in lobbying income.
Lobbying for Sumitomo Pharma America, Inc. · Manufacturer of oncology, rare disease, CNS, urology, and women's health treatments.
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 17, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
Massachusetts
Lobbying activity
2
Issues related to prescription drug pricing, and issues related to small to mid-size pharmaceutical companies.
Issues related to prescription drug pricing, and issues related to small to mid-size pharmaceutical companies.